10-Q Filing

PFIZER INC CIK: 78003 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0000078003-23-000115`
Period End Date	20230930
Filing Date	20231108
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	pfe-20231001_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 92 Cash Flow Statement 86 Stockholders Equity 41 Comprehensive Income 68

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$465.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$449.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$416.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.15B	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.17B	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.78B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.26B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.56B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$41.03B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$22.32B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2023$465; 2022$449	`AccountsReceivableNetCurrent`	$10.95B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2023$465; 2022$449	`AccountsReceivableNetCurrent`	$11.09B	USD	Point-in-time
Inventories	`InventoryNet`	$10.20B	USD	Point-in-time
Inventories	`InventoryNet`	$8.98B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.58B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.92B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.62B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.02B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$51.26B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$74.01B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$11.03B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$11.03B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$3.21B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$4.04B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2023$15,779; 2022$15,174	`PropertyPlantAndEquipmentNet`	$17.86B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2023$15,779; 2022$15,174	`PropertyPlantAndEquipmentNet`	$16.27B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$40.22B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$43.37B	USD	Point-in-time
Goodwill	`Goodwill`	$51.53B	USD	Point-in-time
Goodwill	`Goodwill`	$51.38B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$6.69B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$8.35B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$8.81B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$13.16B	USD	Point-in-time
Total assets	`Assets`	$215.02B	USD	Point-in-time
Total assets	`Assets`	$197.21B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2023$2,260; 2022$2,560	`DebtCurrent`	$2.94B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2023$2,260; 2022$2,560	`DebtCurrent`	$2.55B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$5.34B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$6.81B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.30B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.59B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.90B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$3.41B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$2.37B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$2.52B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$2.20B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$22.57B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.78B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.14B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$42.14B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$32.88B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$61.05B	USD	Point-in-time
Pension and postretirement benefit obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$2.17B	USD	Point-in-time
Pension and postretirement benefit obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$2.25B	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$1.02B	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$1.12B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$8.10B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$9.81B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$14.24B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$13.18B	USD	Point-in-time
Total liabilities	`Liabilities`	$101.29B	USD	Point-in-time
Total liabilities	`Liabilities`	$117.82B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$478.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$476.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$92.50B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$91.80B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$114.48B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$113.97B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$125.66B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$126.41B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.30B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-7.97B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$96.93B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$95.66B	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$256.00M	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$270.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$99.29B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.89B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$97.20B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.47B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.92B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$215.02B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$197.21B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$13.23B	USD	1 Quarter
Revenues	`Revenues`	$22.64B	USD	1 Quarter
Revenues	`Revenues`	$76.04B	USD	3 Qtrs
Revenues	`Revenues`	$44.25B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$6.06B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$17.39B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$24.70B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$9.27B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.39B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.28B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$10.20B	USD	3 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$9.03B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$7.86B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$7.81B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.70B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.71B	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$67.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$524.00M	USD	1 Quarter
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$880.00M	USD	3 Qtrs
Acquired in-process research and development expenses	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$122.00M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$2.48B	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$1.18B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$822.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$3.47B	USD	3 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$199.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$377.00M	USD	3 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$580.00M	USD	3 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$155.00M	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-1.06B	USD	3 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$356.00M	USD	3 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$59.00M	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$79.00M	USD	1 Quarter
Income/(loss) from continuing operations before provision/(benefit) for taxes on income/(loss)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.35B	USD	1 Quarter
Income/(loss) from continuing operations before provision/(benefit) for taxes on income/(loss)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$29.50B	USD	3 Qtrs
Income/(loss) from continuing operations before provision/(benefit) for taxes on income/(loss)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.19B	USD	3 Qtrs
Income/(loss) from continuing operations before provision/(benefit) for taxes on income/(loss)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.00B	USD	1 Quarter
Provision/(benefit) for taxes on income/(loss)	`IncomeTaxExpenseBenefit`	$-964.00M	USD	1 Quarter
Provision/(benefit) for taxes on income/(loss)	`IncomeTaxExpenseBenefit`	$-320.00M	USD	3 Qtrs
Provision/(benefit) for taxes on income/(loss)	`IncomeTaxExpenseBenefit`	$3.10B	USD	3 Qtrs
Provision/(benefit) for taxes on income/(loss)	`IncomeTaxExpenseBenefit`	$356.00M	USD	1 Quarter
Income/(loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$26.40B	USD	3 Qtrs
Income/(loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.51B	USD	3 Qtrs
Income/(loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.64B	USD	1 Quarter
Income/(loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-2.39B	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$11.00M	USD	3 Qtrs
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$12.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-21.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$4.00M	USD	3 Qtrs
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$-2.38B	USD	1 Quarter
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$8.62B	USD	1 Quarter
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$5.52B	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$27.00M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$15.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$30.00M	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$8.61B	USD	1 Quarter
Net income/(loss) attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$5.49B	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$26.38B	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$-2.38B	USD	1 Quarter
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.54	USD	1 Quarter
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.97	USD	3 Qtrs
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$4.70	USD	3 Qtrs
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.42	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.97	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.54	USD	1 Quarter
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$4.71	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$-0.42	USD	1 Quarter
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.96	USD	3 Qtrs
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.42	USD	1 Quarter
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.51	USD	1 Quarter
Income/(loss) from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$4.60	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$4.60	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.96	USD	3 Qtrs
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.51	USD	1 Quarter
Net income/(loss) attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$-0.42	USD	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.61B	shares	3 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.65B	shares	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.64B	shares	3 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.61B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.71B	shares	3 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.73B	shares	3 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.72B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.65B	shares	1 Quarter

Cash Flow Statement 86 line items

Line Item	Tag	Value	Unit	Period
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$-2.38B	USD	1 Quarter
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$8.62B	USD	1 Quarter
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$5.52B	USD	3 Qtrs
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$4.00M	USD	3 Qtrs
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-21.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$12.00M	USD	1 Quarter
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$11.00M	USD	3 Qtrs
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-2.39B	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$26.40B	USD	3 Qtrs
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.64B	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.51B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.54B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.62B	USD	3 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$287.00M	USD	3 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$499.00M	USD	3 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$-3.40B	USD	3 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.58B	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$508.00M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$404.00M	USD	3 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$532.00M	USD	3 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$467.00M	USD	3 Qtrs
Inventory write-offs and related charges associated with COVID-19 products	`InventoryWriteDown`	$476.00M	USD	3 Qtrs
Inventory write-offs and related charges associated with COVID-19 products	`InventoryWriteDown`	$5.85B	USD	3 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$-1.48B	USD	3 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$744.00M	USD	3 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$10.62B	USD	3 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$8.08B	USD	3 Qtrs
Net cash provided by/(used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$20.68B	USD	3 Qtrs
Net cash provided by/(used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.46B	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.86B	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.23B	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$29.70B	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$30.14B	USD	3 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$18.02B	USD	3 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$35.09B	USD	3 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$10.88B	USD	3 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$6.10B	USD	3 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$166.00M	USD	3 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$1.63B	USD	3 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$446.00M	USD	3 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$189.00M	USD	3 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$25.00M	USD	3 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.22B	USD	3 Qtrs
Dividend received from the Consumer Healthcare JV	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$3.96B	USD	3 Qtrs
Dividend received from the Consumer Healthcare JV	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$200.00M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$193.00M	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-21.28B	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.37B	USD	3 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$14.00M	USD	3 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$3.89B	USD	3 Qtrs
Payments on short-term borrowings	`RepaymentsOfShortTermDebt`	-	USD	3 Qtrs
Payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$3.89B	USD	3 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$870.00M	USD	3 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$-106.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$30.83B	USD	3 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$1.61B	USD	3 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$2.57B	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$6.74B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$6.93B	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-613.00M	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-342.00M	USD	3 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.62B	USD	3 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.82B	USD	3 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-139.00M	USD	3 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-39.00M	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-646.00M	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.76B	USD	3 Qtrs
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.34B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.00M	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.00M	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.23B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.34B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$2.91B	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	$4.92B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.15B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.12B	USD	3 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$98.00M	USD	3 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$28.00M	USD	3 Qtrs

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.82	USD	3 Qtrs
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	-	USD	1 Quarter
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.40	USD	1 Quarter
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.20	USD	3 Qtrs
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.47B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.92B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.89B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$99.29B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$97.20B	USD	Point-in-time
Net income/(loss)	`ProfitLoss`	$-2.38B	USD	1 Quarter
Net income/(loss)	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income/(loss)	`ProfitLoss`	$8.62B	USD	1 Quarter
Net income/(loss)	`ProfitLoss`	$5.52B	USD	3 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$134.00M	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.34B	USD	3 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$330.00M	USD	3 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-1.11B	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$2.25B	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$6.73B	USD	3 Qtrs
Common stock	`DividendsCommonStockCash`	$4.63B	USD	3 Qtrs
Common stock	`DividendsCommonStockCash`	-	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$8.00M	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$7.00M	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$7.00M	USD	3 Qtrs
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$8.00M	USD	3 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$161.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$161.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$77.00M	USD	3 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$108.00M	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$2.00B	USD	3 Qtrs
Other	`StockholdersEquityOther`	$4.00M	USD	3 Qtrs
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	-	USD	3 Qtrs
Other	`StockholdersEquityOther`	-	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.47B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$97.20B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$99.29B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$92.89B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.92B	USD	Point-in-time

Comprehensive Income 68 line items

Line Item	Tag	Value	Unit	Period
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$-2.38B	USD	1 Quarter
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$26.40B	USD	3 Qtrs
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$8.62B	USD	1 Quarter
Net income/(loss) before allocation to noncontrolling interests	`ProfitLoss`	$5.52B	USD	3 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-109.00M	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$234.00M	USD	3 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-918.00M	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-2.55B	USD	3 Qtrs
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$1.44B	USD	3 Qtrs
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$408.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$589.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$519.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$972.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$67.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-73.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$615.00M	USD	1 Quarter
Other comprehensive income (loss), cash flow hedge, gain (loss), before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$341.00M	USD	1 Quarter
Other comprehensive income (loss), cash flow hedge, gain (loss), before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-26.00M	USD	1 Quarter
Other comprehensive income (loss), cash flow hedge, gain (loss), before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$593.00M	USD	3 Qtrs
Other comprehensive income (loss), cash flow hedge, gain (loss), before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$471.00M	USD	3 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.40B	USD	3 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-83.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$30.00M	USD	3 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-777.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$442.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-606.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-51.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income/(loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-1.09B	USD	3 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-303.00M	USD	3 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-32.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-411.00M	USD	3 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-171.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-88.00M	USD	3 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-99.00M	USD	3 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-29.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-31.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$2.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-8.00M	USD	3 Qtrs
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-14.00M	USD	3 Qtrs
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-1.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service costs and other, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$107.00M	USD	3 Qtrs
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service costs and other, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$29.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service costs and other, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$30.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service costs and other, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$102.00M	USD	3 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-1.14B	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-2.49B	USD	3 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$313.00M	USD	3 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$170.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$36.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-17.00M	USD	3 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-149.00M	USD	3 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-33.00M	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-2.34B	USD	3 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$330.00M	USD	3 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-1.11B	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$134.00M	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.51B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-2.24B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.85B	USD	3 Qtrs
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$24.07B	USD	3 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$16.00M	USD	3 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$10.00M	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$23.00M	USD	3 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$-2.25B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$24.05B	USD	3 Qtrs
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$7.50B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$5.83B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.